PubMed

Alogliptin Use in Elderly People: A Pooled Analysis from Phase 2 and 3 Studies.

Pratley RE, McCall T, Fleck PR, Wilson CA, Mekki Q.

J Am Geriatr Soc. 2009 Sep 30. [Epub ahead of print]PMID: 19793357 [PubMed - as supplied by publisher]Related articles

Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA(1C) without causing weight gain or increased hypoglycaemia.

Rosenstock J, Rendell MS, Gross JL, Fleck PR, Wilson CA, Mekki Q.

Diabetes Obes Metab. 2009 Dec;11(12):1145-52. Epub 2009 Sep 16.PMID: 19758359 [PubMed - in process]Related articles

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study.

Pratley RE, Reusch JE, Fleck PR, Wilson CA, Mekki Q; Alogliptin Study 009 Group.

Curr Med Res Opin. 2009 Oct;25(10):2361-71.PMID: 19650752 [PubMed - in process]Related articles

Coadministration of pioglitazone or glyburide and alogliptin: pharmacokinetic drug interaction assessment in healthy participants.

Karim A, Laurent A, Munsaka M, Wann E, Fleck P, Mekki Q.

J Clin Pharmacol. 2009 Oct;49(10):1210-9. Epub 2009 Jul 21.PMID: 19622714 [PubMed - in process]Related articles

Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study.

Nauck MA, Ellis GC, Fleck PR, Wilson CA, Mekki Q; Alogliptin Study 008 Group.

Int J Clin Pract. 2009 Jan;63(1):46-55.PMID: 19125992 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy.

Pratley RE, Kipnes MS, Fleck PR, Wilson C, Mekki Q; Alogliptin Study 007 Group.

Diabetes Obes Metab. 2009 Feb;11(2):167-76.PMID: 19125778 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes and inadequate glycemic control: a randomized, double-blind, placebo-controlled study.

DeFronzo RA, Fleck PR, Wilson CA, Mekki Q; Alogliptin Study 010 Group.

Diabetes Care. 2008 Dec;31(12):2315-7. Epub 2008 Sep 22.PMID: 18809631 [PubMed - indexed for MEDLINE]Related articlesFree article

Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects.

Christopher R, Covington P, Davenport M, Fleck P, Mekki QA, Wann ER, Karim A.

Clin Ther. 2008 Mar;30(3):513-27.PMID: 18405789 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: a randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes.

Covington P, Christopher R, Davenport M, Fleck P, Mekki QA, Wann ER, Karim A.

Clin Ther. 2008 Mar;30(3):499-512.PMID: 18405788 [PubMed - indexed for MEDLINE]Related articles

Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience.

Yocum DE, Furst DE, Bensen WG, Burch FX, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisememandle W, Mekki QA; Tacrolimus RA Study Group.

Rheumatology (Oxford). 2004 Aug;43(8):992-9. Epub 2004 Mar 10.PMID: 15014199 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: a double-blind trial.

Yocum DE, Furst DE, Kaine JL, Baldassare AR, Stevenson JT, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisemandle W, Mekki QA; Tcrolimus Rheumatoid Arthritis Study Group.

Arthritis Rheum. 2003 Dec;48(12):3328-37.PMID: 14673984 [PubMed - indexed for MEDLINE]Related articlesFree article

Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study.

Kremer JM, Habros JS, Kolba KS, Kaine JL, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisemandle W, Mekki QA; Tacrolimus-Methotrexate Rheumatoid Arthritis Study Group.

Arthritis Rheum. 2003 Oct;48(10):2763-8.PMID: 14558080 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparative tacrolimus pharmacokinetics: normal versus mildly hepatically impaired subjects.

Bekersky I, Dressler D, Alak A, Boswell GW, Mekki QA.

J Clin Pharmacol. 2001 Jun;41(6):628-35.PMID: 11402631 [PubMed - indexed for MEDLINE]Related articles

Effect of time of meal consumption on bioavailability of a single oral 5 mg tacrolimus dose.

Bekersky I, Dressler D, Mekki Q.

J Clin Pharmacol. 2001 Mar;41(3):289-97.PMID: 11269569 [PubMed - indexed for MEDLINE]Related articles

Effect of low- and high-fat meals on tacrolimus absorption following 5 mg single oral doses to healthy human subjects.

Bekersky I, Dressler D, Mekki QA.

J Clin Pharmacol. 2001 Feb;41(2):176-82.PMID: 11210398 [PubMed - indexed for MEDLINE]Related articles

Coadministration of tacrolimus and mycophenolate mofetil in stable kidney transplant patients: pharmacokinetics and tolerability.

Pirsch J, Bekersky I, Vincenti F, Boswell G, Woodle ES, Alak A, Kruelle M, Fass N, Facklam D, Mekki Q.

J Clin Pharmacol. 2000 May;40(5):527-32.PMID: 10806606 [PubMed - indexed for MEDLINE]Related articles

Dose linearity after oral administration of tacrolimus 1-mg capsules at doses of 3, 7, and 10 mg.

Bekersky I, Dressler D, Mekki QA.

Clin Ther. 1999 Dec;21(12):2058-64.PMID: 10645753 [PubMed - indexed for MEDLINE]Related articles

Bioequivalence of 1 and 5 mg tacrolimus capsules using a replicate study design.

Bekersky I, Dressler D, Colburn W, Mekki Q.

J Clin Pharmacol. 1999 Oct;39(10):1032-7.PMID: 10516937 [PubMed - indexed for MEDLINE]Related articles

Bioequivalence of a new strength tacrolimus capsule under development.

Bekersky I, Dressler D, Boswell GW, Fergen B, Tracewell W, Mekki Q.

Transplant Proc. 1998 Jun;30(4):1457-9. No abstract available. PMID: 9636591 [PubMed - indexed for MEDLINE]Related articles

Demographic considerations in tacrolimus pharmacokinetics.

Fitzsimmons WE, Bekersky I, Dressler D, Raye K, Hodosh E, Mekki Q.

Transplant Proc. 1998 Jun;30(4):1359-64. No abstract available. PMID: 9636552 [PubMed - indexed for MEDLINE]Related articles

Plasma concentrations and disposition of clonidine following a constant 14-day epidural infusion in cancer patients.

Boswell G, Bekersky I, Mekki Q, Eisenach J.

Clin Ther. 1997 Sep-Oct;19(5):1024-30.PMID: 9385489 [PubMed - indexed for MEDLINE]Related articles

Tacrolimus oral bioavailability doubles with coadministration of ketoconazole.

Floren LC, Bekersky I, Benet LZ, Mekki Q, Dressler D, Lee JW, Roberts JP, Hebert MF.

Clin Pharmacol Ther. 1997 Jul;62(1):41-9.PMID: 9246018 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics of tacrolimus in liver transplant patients.

Jusko WJ, Piekoszewski W, Klintmalm GB, Shaefer MS, Hebert MF, Piergies AA, Lee CC, Schechter P, Mekki QA.

Clin Pharmacol Ther. 1995 Mar;57(3):281-90.PMID: 7535213 [PubMed - indexed for MEDLINE]Related articles

Dopamine-2 receptor blockade does not affect the ocular hypotensive action of timolol.

Mekki QA, Turner P.

Br J Ophthalmol. 1988 Aug;72(8):598-600.PMID: 3415954 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of cicloprolol in intraocular pressure in healthy volunteers.

Mekki QA, Turner P.

Br J Clin Pharmacol. 1988 Jul;26(1):89-91.PMID: 2904826 [PubMed - indexed for MEDLINE]Related articlesFree article

Stimulation of dopamine receptors (type 2) lowers human intraocular pressure.

Mekki QA, Turner P.

Br J Ophthalmol. 1985 Dec;69(12):909-10.PMID: 4084483 [PubMed - indexed for MEDLINE]Related articlesFree article

Indomethacin does not attenuate the ocular hypotensive effect of timolol.

Mekki QA, Abrams SM, Petounis AD, Turner P.

Br J Clin Pharmacol. 1985 Apr;19(4):523-4. No abstract available. PMID: 3888242 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of atenolol on red blood cell deformability.

Sinawi Lubna AH, Sowemimo-Coker SO, Mekki QA, Turner P.

Eur J Clin Pharmacol. 1985;28(4):483. No abstract available. PMID: 4029254 [PubMed - indexed for MEDLINE]Related articles

Effect of a hydantoin prostaglandin analogue, BW245C, during oral dosing in man.

Al-Sinawi LA, Mekki QA, Hassan S, Hedges A, Burke C, Moody SG, O'Grady J.

Prostaglandins. 1985 Jan;29(1):99-111.PMID: 3975430 [PubMed - indexed for MEDLINE]Related articles

A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man.

O'Grady J, Hedges A, Whittle BJ, Al-Sinawi LA, Mekki QA, Burke C, Moody SG, Moti MJ, Hassan S.

Br J Clin Pharmacol. 1984 Dec;18(6):921-33.PMID: 6085004 [PubMed - indexed for MEDLINE]Related articlesFree article

Bromocriptine in glaucoma.

Mekki QA, Turner P.

Lancet. 1984 Jul 28;2(8396):236. No abstract available. PMID: 6146800 [PubMed - indexed for MEDLINE]Related articles

Bromocriptine eyedrops lower intraocular pressure without affecting prolactin levels.

Mekki QA, Warrington SJ, Turner P.

Lancet. 1984 Feb 4;1(8371):287-8. No abstract available. PMID: 6143030 [PubMed - indexed for MEDLINE]Related articles

Bromocriptine lowers intraocular pressure without affecting blood pressure.

Mekki QA, Hassan SM, Turner P.

Lancet. 1983 Jun 4;1(8336):1250-1.PMID: 6134042 [PubMed - indexed for MEDLINE]Related articles

Local and systemic effects of pindolol eye drops.

Mekki QA, Penhall R, Edgar DF, Stewart-Jones JH, Turner P.

Br J Clin Pharmacol. 1983 Jan;15(1):112-3.PMID: 6849733 [PubMed - indexed for MEDLINE]Related articlesFree article